Hemophilia
📧 Sign up to get email alerts when something new happens for Hemophilia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-10-03Clinical Trial Update: Efficacy and Safety Study of SCT800 for On-demand Treatment With in Patients With Hemophilia A [Phase 3]
Phase 3 efficacy and safety study update for SCT800 in on-demand treatment of Hemophilia A; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2016-09-26Clinical Trial Update: Hepatitis C in Clinically Discordant Hemophilic Siblings
A completed clinical trial update from UNC Chapel Hill reports on Hepatitis C infection in clinically discordant siblings with Hemophilia A.
-
CLINICAL_TRIALS trial_result · 2016-09-22Clinical Trial Update: Evaluation of Clot Stability Induced by Solulin: Evaluation of New Solulin Mutants Lacking Protein C Activation Capacity
A completed clinical trial evaluating clot stability induced by Solulin mutants lacking protein C activation capacity in Hemophilia A.
-
CLINICAL_TRIALS trial_result · 2016-09-20Clinical Trial Update: Outcomes of Prophylaxis and On-demand Treatment for Severe Hemophiliacs and Collection of Baseline Data in Hemophiliacs in Taiwan
This clinical trial update reports outcomes of prophylaxis and on-demand treatment for severe hemophilia patients in Taiwan and notes collec…
-
CLINICAL_TRIALS trial_result · 2016-09-19Clinical Trial Update: Hemophilia Adult Prophylaxis Study: Factor VIII in Severe Hemophilia A [Phase 3]
Phase 3 trial evaluating adult prophylaxis with Factor VIII in severe Hemophilia A has been terminated; results have been posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-09-07Clinical Trial Update: Study Investigating a PEGylated Recombinant Factor VIII (BAX 855) for Hemophilia A (PROLONG-ATE Study) [Phase 2, Phase 3]
Study update on PEGylated recombinant Factor VIII (BAX 855) for Hemophilia A completed with posted results.
-
CLINICAL_TRIALS research · 2016-09-02Clinical Trial Update: Pharmacokinetic Study of SCT800 in Previously Treated Patients With Hemophilia A [Phase 1]
Phase 1 pharmacokinetic study update of SCT800 in previously treated patients with Hemophilia A. The current trial status is unknown.
-
CLINICAL_TRIALS trial_result · 2016-09-01Clinical Trial Update: BAX 326 Pediatric Study [Phase 2, Phase 3]
Clinical trial update for BAX 326 in pediatric patients completed phases 2 and 3 with results posted in 2016.
-
CLINICAL_TRIALS research · 2016-08-31Clinical Trial Update: Global Hemostatic Methods in Hemophilia and Von Willebrand's Disease
This clinical trial update reports ongoing research on global hemostatic methods for Hemophilia A, Hemophilia B, and von Willebrand disease …
-
CLINICAL_TRIALS withdrawal · 2016-08-23Clinical Trial Update: Study of Recombinant Factor IX Product, IB1001, in Previously Treated Subjects With Hemophilia B [Phase 3]
Phase 3 trial of IB1001, a recombinant Factor IX product, for Hemophilia B has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-08-19Clinical Trial Update: Pharmacokinetics of rFVIIIFc at Two Vial Strengths [Phase 1]
Phase 1 pharmacokinetics study of rFVIIIFc at two vial strengths in adults with severe hemophilia A; completed with results posted.
-
CLINICAL_TRIALS research · 2016-08-17Clinical Trial Update: Personalized Prophylactic Treatment With Advate® in Severe or Moderate Haemophilia A Patients
Clinical trial update examining personalized prophylactic treatment with Advate (factor VIII recombinant) for people with severe or moderate…
-
CLINICAL_TRIALS trial_result · 2016-08-09Clinical Trial Update: An Open-label Safety, Efficacy and Pharmacokinetic Study of a Recombinant FVIII Compared to Recombinant Human Antihemophilic FVIII in Patients With Severe Hemophilia A [Phase 2, Phase 3]
An open-label Phase 2/3 trial in severe Hemophilia A evaluated the safety, efficacy, and pharmacokinetics of a recombinant factor VIII compa…
-
CLINICAL_TRIALS research · 2016-08-03Clinical Trial Update: Socialization of Adult Men With Congenital Hemophilia A or B
A completed clinical trial investigating socialization in adult men with congenital Hemophilia A or B. The summary provided does not specify…
-
CLINICAL_TRIALS trial_result · 2016-07-25Clinical Trial Update: An Open-Label, Single Dose Pharmacokinetic Study of Benefix (Recombinant Factor IX) in Male Chinese Subjects With Hemophilia B [Phase 1]
This is an open-label, single-dose Phase 1 pharmacokinetic study of Benefix (recombinant factor IX) in male Chinese subjects with Hemophilia…
-
CLINICAL_TRIALS trial_result · 2016-07-19Clinical Trial Update: Input of a Multidisciplinary Device to Accompany the Announce of Diagnosis for Young Children With Serious Constitutional Hemorrhagic Disease and Their Families [NA]
This update notes the completion of a clinical trial evaluating a multidisciplinary device to accompany the diagnosis announcement for young…
-
CLINICAL_TRIALS trial_result · 2016-07-07Clinical Trial Update: Educational Physiotherapy in Haemophilia [NA]
A completed clinical trial (NCT02825706) evaluating educational physiotherapy for individuals with hemophilia.
-
CLINICAL_TRIALS research · 2016-07-01Clinical Trial Update: Validation of Questionnaires HAL and HEP
This document reports on an ongoing study validating the HAL and HEP questionnaires for hemophilia patients. It is sponsored by Universidad …
-
CLINICAL_TRIALS trial_result · 2016-06-30Clinical Trial Update: Effectiveness of the uPatient Platform in Prophylactic Treatment in Hemophilia
The document reports on the effectiveness of the uPatient Platform in prophylactic treatment for hemophilia.
-
CLINICAL_TRIALS trial_result · 2016-06-15Clinical Trial Update: Study of PF-05208756, Moroctocog Alfa (AF-CC), Xyntha For Male Chinese Subjects With Hemophilia A [Phase 1]
Phase 1 clinical trial evaluating PF-05208756 and Moroctocog alfa (AF-CC) with Xyntha in male Chinese subjects with Hemophilia A has complet…
-
CLINICAL_TRIALS trial_result · 2016-06-14Clinical Trial Update: Hepatitis Delta Infections in Hemophiliacs
Clinical trial evaluating Hepatitis D infections in individuals with hemophilia has completed. The snippet does not include trial results.
-
CLINICAL_TRIALS trial_result · 2016-05-13Clinical Trial Update: A Single Dose Trial Investigating Safety and Local Tolerability of Ascending Doses of Long Acting Activated Recombinant Human Factor VII in Healthy Male Volunteers [Phase 1]
A Phase 1 study evaluating the safety and local tolerability of escalating doses of a long-acting activated recombinant human Factor VII in …
-
CLINICAL_TRIALS research · 2016-05-13Clinical Trial Update: Epidemiology and Immunology of Hemophilia A Inhibitors
This completed NHLBI-sponsored clinical trial update investigates the epidemiology and immunology of inhibitors in Hemophilia A.
-
CLINICAL_TRIALS trial_result · 2016-05-12Clinical Trial Update: Intra-subject Variability Following Administrations of Activated Recombinant Human Factor VII in Haemophilia Patients in a Non-bleeding State [Phase 1]
Phase 1 trial update assessing intra-subject variability after administration of activated recombinant human Factor VII (eptacog alfa) in he…
-
CLINICAL_TRIALS trial_result · 2016-05-12Clinical Trial Update: Covalent Tolerance Induction to Factor VIII-Prediction of Inhibitors in Hemophilia
A completed clinical trial from The University of Texas Health Science Center investigating covalent tolerance induction to Factor VIII to p…